Bob Dole appeared in its commercials in the '90s, before the blue pill with a funny name entered the public lexicon, impotence was hush-hush. Now there's no getting away from it. In-boxes are clogged ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Experts urge caution in interpreting results of a small pilot study finding microplastics in prostate cancer tissue, calling the results provocative but preliminary.

By Puyaan Singh and Sahil Pandey March 6 (Reuters) - The U.S. Food and Drug Administration on Friday approved a new formulation of Lantheus Holdings' prostate cancer imaging agent, aimed at improving ...

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...

Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...

KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.

Dr. Matthew Galsky spoke with CURE about the KEYNOTE-B15 trial results and their potential impact on muscle-invasive bladder cancer care. At the 2026 ASCO Genitourinary Cancers Symposium, the ...

The pioneering procedure went 'extremely well', with patient Paul Buxton reporting feeling 'fantastic' just four days after the surgery which he did from 2,400 km away ...